Separation of anxiety and depressive disorders

BMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7419.870 (Published 09 October 2003) Cite this as: BMJ 2003;327:870

Maybe pharmaceutical failure has created culture of niche diagnosis

  1. Michael Joffe, reader in epidemiology (m.joffe@imperial.ac.uk)
  1. Department of Epidemiology, Imperial College, St Mary's Campus, London W2 1PG

    EDITOR—Shorter and Tyrer provide an important case study in the way that medicine and science can become subverted by commercial pressures.1 On one hand, new patents for drugs for mood and anxiety disorders have dwindled to almost nothing from a high point in the 1960s and 1970s. On the other, niche diagnoses have proliferated, apparently as a result of collusion between …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription